Nature's Sunshine Earnings Reports

Nature's Sunshine experienced strong revenue growth of 8.5% in Q4 2024, driven by double-digit gains in the Asia segment. However, rising selling, general, and administrative (SG&A) expenses and foreign exchange losses led to a net loss of $0.3 million. Adjusted EBITDA grew by 6% to $10.3 million, reflecting continued operational efficiency improvements.

Nature's Sunshine reported a 3% increase in net sales to $114.6 million for the third quarter of 2024, driven by strong customer growth in Japan and Taiwan, and progress in Korea. GAAP net income attributable to common shareholders increased to $4.3 million, or $0.23 per diluted common share. The positive momentum was offset by macroeconomic headwinds in China.

Nature's Sunshine's Q2 2024 net sales decreased by 5% to $110.6 million, and GAAP net income attributable to common shareholders decreased to $1.3 million, or $0.07 per diluted common share. The company faced macroeconomic challenges in China, slowing consumer spending in the U.S., and a temporary disruption in North America. Despite these challenges, Nature's Sunshine implemented strategic actions, including upgrading the digital platform, rebalancing the consumer proposition in Asia/Pacific, and streamlining overhead expenses.

Nature's Sunshine reported a 2% increase in net sales to $111.0 million, with a 4% increase in constant currency. GAAP net income attributable to common shareholders significantly increased to $2.3 million, or $0.12 per diluted share. Adjusted EBITDA increased slightly to $9.2 million.

Nature's Sunshine Products reported a 6.0% increase in net sales for Q4 2023, reaching $108.9 million. GAAP net income attributable to common shareholders significantly increased to $9.0 million, or $0.46 per diluted share. Adjusted EBITDA rose by 21% to $9.7 million.

Nature's Sunshine reported a strong third quarter with net sales increasing by 6% to $111.2 million. GAAP net income attributable to common shareholders increased significantly to $2.8 million, or $0.15 per diluted common share. Adjusted EBITDA was up 50% to $10.3 million.

Nature's Sunshine reported a strong second quarter in 2023, with net sales increasing by 12% to $116.5 million and adjusted EBITDA up by 26% to $11.3 million. The company's GAAP net income attributable to common shareholders increased significantly to $2.4 million, or $0.12 per diluted common share. The growth was driven by strength in Asia/Pacific, stabilization in Central and Eastern Europe, and a return to growth in North America.

Nature's Sunshine reported net sales of $108.6 million, a GAAP net income of $1.3 million, and an adjusted EBITDA of $9.1 million for the first quarter of 2023.

Nature's Sunshine reported a decrease in net sales for Q4 2022 compared to the same period last year, primarily due to foreign exchange headwinds. However, the company saw strong growth in Asia. The company is focused on investing in digital, field activation, manufacturing efficiency, and brand-building to drive future growth.

Nature's Sunshine's net sales were $104.2 million compared to $109.0 million in the same year-ago quarter. GAAP net income was $1.0 million, or $0.03 per diluted common share, compared to $6.8 million, or $0.32 per diluted common share. Adjusted EBITDA was $9.0 million compared to $13.4 million.

Nature's Sunshine reported an 8% increase in net sales, reaching a record $110.5 million, but experienced a GAAP net loss of $2.7 million, or $(0.15) per diluted share. The company faced headwinds from COVID-19, global supply chain issues, inflation, and the war in Ukraine, which negatively impacted productivity and resulted in inventory-related impairment charges.

Nature's Sunshine Products Inc. reported a record fourth quarter with net sales up 15.9% to $117.9 million and GAAP net income increasing 107.6% to $13.8 million, or $0.67 per diluted share. The company's adjusted EBITDA also increased by 54.7% to $11.6 million. They also announced a $30 million share repurchase program.

Nature's Sunshine Products reported a record first quarter in 2021, with net sales reaching $102.4 million, a 7% increase compared to the previous year. GAAP net income increased significantly to $4.2 million, or $0.20 per diluted share. Non-GAAP net income per diluted share was $0.21. Adjusted EBITDA increased 20% to $11.6 million.

Nature's Sunshine reported record fourth-quarter net sales of $101.7 million, an 11% increase year-over-year. GAAP net income significantly increased to $6.7 million, or $0.29 per diluted share, compared to $1.2 million, or $0.05 per diluted share in the same quarter last year. The company's board of directors declared a special cash dividend of $1.00 per share and announced a $15 million share repurchase program.

Nature's Sunshine reported a 13% increase in net sales, reaching a company record of $100.3 million. GAAP net income significantly increased to $7.2 million, or $0.34 per diluted share, compared to $1.4 million, or $0.07 per diluted share in the same quarter last year.

Nature's Sunshine's net sales were $87.3 million compared to $90.7 million in the same year‐ago quarter. GAAP net income increased significantly to $6.1 million, or $0.29 per diluted share, compared to $2.6 million, or $0.14 per diluted share. Adjusted EBITDA increased 21% to $9.7 million compared to $8.0 million.

Nature's Sunshine Products reported a 5.1% increase in net sales to $95.9 million, with GAAP net income rising to $3.0 million from $1.7 million in the prior year. The company experienced growth in Europe and North America, offset by declines in Asia.

Nature's Sunshine Products reported a decrease in net sales for Q4 2019, but experienced significant improvements in GAAP net income and adjusted EBITDA compared to the prior year. The company focused on its Global Growth Strategy and cost reduction measures, leading to improved profitability.